ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 67 filers reported holding ADICET BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $12,617 | +33.5% | 5,369 | +7.3% | 0.00% | – |
| Q4 2023 | $9,454 | +2.9% | 5,002 | -25.4% | 0.00% | – |
| Q3 2023 | $9,186 | -62.6% | 6,705 | -33.7% | 0.00% | – |
| Q2 2023 | $24,565 | -84.9% | 10,109 | -64.1% | 0.00% | – |
| Q1 2023 | $162,259 | -34.6% | 28,170 | +1.5% | 0.00% | – |
| Q4 2022 | $248,112 | -34.5% | 27,753 | +4.1% | 0.00% | -100.0% |
| Q3 2022 | $379,000 | -4.8% | 26,662 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $398,000 | +80.9% | 27,280 | +147.5% | 0.00% | – |
| Q1 2022 | $220,000 | +11.7% | 11,022 | -1.9% | 0.00% | – |
| Q4 2021 | $197,000 | +123.9% | 11,240 | 0.0% | 0.00% | – |
| Q3 2021 | $88,000 | -70.4% | 11,240 | -61.0% | 0.00% | – |
| Q2 2021 | $297,000 | – | 28,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $42,160,000 | 11.96% |
| Foresite Capital Management V, LLC | 680,000 | $13,580,000 | 5.55% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $3,395,000 | 4.75% |
| Tri Locum Partners LP | 523,256 | $10,449,000 | 4.08% |
| DAFNA Capital Management LLC | 715,872 | $14,296,000 | 3.72% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $11,583,000 | 3.55% |
| COWEN AND COMPANY, LLC | 1,500,055 | $29,956,000 | 2.88% |
| JOHNSON & JOHNSON | 728,944 | $14,557,000 | 2.75% |
| Orbimed Advisors | 7,447,141 | $148,719,000 | 2.41% |
| Ikarian Capital, LLC | 507,348 | $10,132,000 | 1.33% |